Abcam - Appointment of Chief Financial Officer

Written by: editor@pharmiweb.com
Published On: 14 Jan 2020

Abcam plc ("Abcam" or "the Company", AIM: ABC), a global leader in the supply of life science research tools, is pleased to announce the appointment of Michael Baldock as Chief Financial Officer with effect from 3 February 2020*.

Michael assumes the role of Chief Financial Officer from Gavin Wood, who notified the Company on 22 July 2019 of his intention to step down from the Board once a successor had been identified.

Michael has over 30 years of relevant functional and sector experience acquired through senior leadership roles at HSBC, Lazard, Bentley Health Care and SG Warburg.  He is a founding partner at Ondra Partners, an independent financial advisory firm which has advised Abcam for several years. The Board believe that his experience, deep sector expertise and knowledge of Abcam make him an ideal candidate to lead Abcam’s financial and strategic growth plans.

Peter Allen, Chairman of Abcam, said: "Following an extensive and thorough process, the Board was unanimous in its view that Michael is the right candidate to join Abcam. We have known and trusted Michael for several years and I am pleased that we have been able to attract him to join us."

Alan Hirzel, Chief Executive Officer of Abcam, added: “Michael’s experience will be valuable for us as we deliver our strategy. His energy and passion for our business will fit well with our teams. We are excited to welcome Michael to the business.”

Michael Baldock commented: "I am excited to be joining Abcam on the next stage of its journey. Having worked closely with Alan and the team, I have been impressed by the Company and its potential. I am looking forward to working with Alan, the Executive Leadership Team and the Board in implementing the Company's strategic vision and delivering continued long term, profitable growth."

Michael will be appointed to the Board on 3 February 2020, and Gavin Wood will step down on this date.

*Michael Baldock’s appointment will be subject to receiving the necessary approval from the UK Home Office allowing him to work in the UK.

AIM Rules disclosures

Full name: Michael Shaun Baldock

Age: 56

Director and / or partner roles held in the five years preceding his appointment at Abcam:

Current Directorships / Partnerships

Previous Directorships / Partnerships

 

Ondra LLP (Partner)

Michael does not currently have an interest in shares in Abcam. 

Save as disclosed above there are no additional disclosures to be made in accordance with Schedule Two paragraph (g) of the AIM Rules.